Nav: Home

NRL, NCATS scientists develop method to safely study COVID-19, other contagious diseases

September 17, 2020

WASHINGTON -- Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences (NCATS), submitted their findings to ACS Nano, a monthly peer-reviewed scientific journal, on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SARS-CoV-2 Spike proteins and human cells.

The manuscript, accepted on Aug. 18, is titled "Quantum Dot-Conjugated SARS-CoV-2 Spike Pseudo-Virions Enable Tracking of Host Cell Surface Angiotensin Converting Enzyme 2 Binding and Endocytosis." SARS-CoV-2 is known to attach to angiotensin converting enzyme 2 (ACE2) receptors via its external 'Spike' proteins, which cover the surface, which the virus uses to bind with and enter human cells.

"We developed nanoparticle-based pseudo-virions that bind to the host cell and track themselves inside of cells without being contagious," said Eunkeu Oh, Ph.D., an NRL biophysicist. "This opens an opportunity to expand the same strategy to various other infectious diseases."

Together with researchers at NCATS, part of the National Institutes of Health (NIH), they worked to develop non-infectious probes to study SARS-CoV-2, which is the causative virus of the current COVID-19 pandemic.

"Simply put, keeping the virus out of cells prevents it from replicating, propagating, and exacerbating infection," said Mason Wolak, Ph.D., acting head of NRL's Optical Nanomaterials Section. "The ultimate goals of the collaboration are to clarify the fundamental mechanisms by which SARS-CoV-2 causes infection and to screen and identify potential drugs to inhibit these mechanisms."

One thing that fascinated the scientists was the potency of the quantum dot nanoparticles to induce translocation of ACE2 from the cell membrane to the interior of the cell through a process called endocytosis. Kirill Gorshkov, Ph.D., an NCATS research scientist, said experiments to block endocytosis prevented internalization of the quantum dot pseudovirus and ACE2 receptor complex.

"While we had some idea that this was possible, the extent to which this occurred with very low amounts of quantum dot pseudo-virions suggested we had a powerful system to track viral attachment and effects on the cell in real time, since these quantum dots are fluorescent," said Gorshkov.

The nanoparticle probes developed at NRL are comprised of multiple Spike protein subunits attached to the surface of a light-emitting quantum dot core.

"We refer to these probes as 'Pseudo-virions' because they approximate the shape of the SARS-CoV-2 virus while also mimicking their physiological interactions with human cells," said Wolak. "Light emitted from the Pseudo-virions allows spatiotemporal tracking of their interaction with human cells."

Wolak went on to say that binding to ACE2 is seen as the initial step of the virus towards cellular infection. Successful inhibition of this binding is an extremely high priority in the search for therapeutic interventions to mitigate the impact of the pandemic on military and public health.

"Protecting the health of deployed warfighters is of the utmost importance to ensure mission readiness and maintain fleet readiness," said Wolak. "Navy ships represent the ultimate 'closed system' - warfighters share close quarters where social distancing is nearly impossible to realistically enforce. This results in conditions that are ripe for rapid and extensive outbreaks, such as the one reported on the USS Theodore Roosevelt, which threaten mission success."

NRL and NCATS are currently designing and testing the feasibility of high-throughput cellular imaging tests to screen entire libraries of therapeutic agents for inhibition of Spike/ACE2 binding and internalization.

"This also opened the door for high-throughput testing of new drugs uncovered by the other approaches at NCATS, to cross-validate the compounds with our system, and to test completely new therapeutic modalities developed at NCATS and elsewhere both biochemically at NRL, and in cell-based assays at NCATS," said Gorshkov.

These tests, carried out at NCATS, would allow for screening of up to 1,536 drug targets per experiment.

"Our team at NRL brings world-class expertise in the field of quantum dot/nanoparticles for biological applications," said Oh. "Merging our resources with the NCATS team's expertise resulted in research that couldn't be done by one team on its own."

Further research is planned to investigate the mechanism that increases infectiousness of SARS-CoV-2 with mutated Spike proteins. The NRL/NCATS team also plans to explore the possibility of using the pseudo-virions for site-specific intracellular drug delivery for purposes of disrupting SARS-CoV-2 replication mechanisms.

Wolak said, "It is very important to note that the Spike-containing pseudo-virion has potential for broad application of intracellular drug delivery to combat not only COVID19, but any disease that targets cells with ACE2 receptors."

Gorshkov said, he hopes the research excites and stimulates the next generation of future researchers to embark on a journey of exploration.

"I hope this story serves to engage young minds into the realm of what is possible when people work together, both scientifically and otherwise," said Gorshkov. "By forging these strong relationships, we can synergize our efforts and come to novel solutions from completely different perspectives and viewpoints."
-end-
About the U.S. Naval Research Laboratory

NRL is a scientific and engineering command dedicated to research that drives innovative advances for the Navy and Marine Corps from the seafloor to space and in the information domain. NRL is located in Washington, D.C., with major field sites in Stennis Space Center, Mississippi; Key West, Florida; and Monterey, California, and employs approximately 2,500 civilian scientists, engineers and support personnel.

Naval Research Laboratory

Related Proteins Articles:

Finding a handle to bag the right proteins
A method that lights up tags attached to selected proteins can help to purify the proteins from a mixed protein pool.
Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.
New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.
Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.
Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.
Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.
Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.
Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.
Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.
How proteins become embedded in a cell membrane
Many proteins with important biological functions are embedded in a biomembrane in the cells of humans and other living organisms.
More Proteins News and Proteins Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.